Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial

Xiaoqiang Liu, Jinzhong Lin, Tao Huang et al.|Human Vaccines & Immunotherapeutics|2025

Cited by 1